Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-24-256045
Filing Date
2024-11-12
Accepted
2024-11-12 16:45:41
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 d809645d424b3.htm 424B3 240954
2 GRAPHIC g809645g44w42.jpg GRAPHIC 47749
3 GRAPHIC g809645g77v37.jpg GRAPHIC 29529
  Complete submission text file 0001193125-24-256045.txt   341735
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

EIN.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-282984 | Film No.: 241449266
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)